Cyanotech Corp (CYAN) 3.90 $CYAN Cyanotech Repo
Post# of 273242
Posted On: 09/19/2016 5:08:04 PM
Cyanotech Corp (CYAN) 3.90 $CYAN
Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2017
BusinessWire - Mon Aug 15, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the first quarter of fiscal year 2017, ended June 30, 2016.
CYAN: 3.90 (-0.10)
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2016
BusinessWire - Thu Jun 23, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the fourth quarter ended March 31, 2016 and fiscal year 2016.
CYAN: 3.90 (-0.10)
Cyanotech Names David Mulder as a Director
BusinessWire - Mon May 23, 7:00AM CDT
The Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN) named David Mulder as a Director of the Company effective May 17, 2016. He replaces Ralph Carlton, who resigned.
CYAN: 3.90 (-0.10)
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2016
BusinessWire - Thu Nov 12, 7:00AM CST
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the second quarter and first six months of fiscal year 2016, ended September 30, 2015.
CYAN: 3.90 (-0.10)
Nutrex Hawaii Announces New Gluten-Free, Grass Free Green Complete(R) Superfood Powder
BusinessWire - Tue Aug 18, 8:00AM CDT
Today, Nutrex Hawaii announced the new blend for Green Complete(R) Superfood Powder. Green Complete Superfood Powder is designed to naturally boost energy and immunity*. The new blend allows greens fans to get their full three gram serving of Hawaiian Spirulina in a certified gluten-free and grass free combination.
CYAN: 3.90 (-0.10)
Cyanotech's net loss narrows to USD105,000 in Q1 fiscal 2016
M2 - Mon Aug 10, 3:06AM CDT
Health products company Cyanotech (Nasdaq CM:CYAN) stated on Friday its net loss was of USD105,000 (USD0.02 per diluted share) for the first quarter of fiscal year 2016, ended 30 June 2015.
CYAN: 3.90 (-0.10)
Cyanotech Adds Astaxanthin Productivity Enhancement
BusinessWire - Fri Jun 12, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), reported today that its new Astaxanthin extraction system has been installed at Cyanotech's production facility at Kailua-Kona, Hawaii and is in operation.
CYAN: 3.90 (-0.10)
Carotenoids Market by Type, Source, Application, & by Region - Global Trends & Forecasts to 2019
M2 - Wed Apr 22, 3:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jx5f7f/carotenoids) has announced the addition of the "Carotenoids Market by Type (Astaxanthin, Beta-Carotene, Canthaxanthin, Lutein, Lycopene, & Zeaxanthin), Source (Synthetic and Natural), Application (Supplements, Food, Feed, and Cosmetics), & by Region - Global Trends & Forecasts to 2019" report to their offering. The market was valued at $1,161.78 million in 2013. It is projected to grow at a CAGR of 3.5% from 2014 to reach $1,428.12 million by 2019 Carotenoids are one of the most important classes of plant pigments and play a very important role in defining the quality parameter of fruit and vegetables. Carotenoids are found mainly in plants, algae, and photosynthetic bacteria; however humans and animals have to rely upon food as a source of these compounds. Carotenoids are gaining significance due to high health benefits, increasing its end-use application and its easy availability. Aging population of the world, especially in the European and North American countries has also boosted the market globally. The market was dominated by Europe in 2013, which accounted for around 42% of the total carotenoids market. However, Asia-Pacific is projected to be the fastest-growing market for the period considered for this study, due to growing demand for food and animal feed and increasing health awareness amongst people. In terms of applications, animal feed is projected to be the largest market for carotenoids from 2014 to 2019; however the supplements market is projected to be the fastest-growing market for the period under study. On the other hand, natural carotenoids are projected to grow at a CAGR of 4.0% for the period under consideration owing to increasing consumers' preferences for natural products and health awareness and concerns. The carotenoids market is characterized by intense competition due to the presence of a large number of both large- and small-scale firms. Expansions, acquisitions, agreements, and new product launches are the key strategies adopted by market players to ensure their growth in the market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Carotenoids Market, By Type 8 Carotenoids Market, By Application 9 Carotenoids Market, By Source 10 Carotenoids Market, By Region 11 Competitive Landscape 12 Company Profiles - Allied Biotech Corporation - BASF SE - CHR. Hansen A/S - Carotech Berhad - Cyanotech Corporation - D.D. Williamson & Co., Inc. - DSM N.V. - Dohler Group - FMC Corporation - Kemin Industries, Inc. For more information visit http://www.researchandmarkets.com/research/jx...arotenoids
CYAN: 3.90 (-0.10), FMC: 47.78 (-0.01)
Global Astaxanthin Market 2015 - Sources, Technologies and Application
M2 - Fri Mar 20, 10:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/558wqg/global) has announced the addition of the "Global Astaxanthin Market - Sources, Technologies and Application" report to their offering. Global market for both synthetic and natural source astaxanthin in aqua feed, nutraceuticals, cosmetics and food & beverages is estimated at 280 metric tons valued at US$447 million in 2014, is further projected to reach 670 metric tons valued at US$1.1 billion by 2020. Synthetic astaxanthin, astaxanthin rich Phaffia yeast and Paracoccus bacteria are predominantly used in the aquaculture sector, while the astaxanthin derived from H. pluvialis microalgae is the main source for human applications such as dietary supplements, cosmetics and food & beverages. Astaxanthin has been widely used in aquaculture industry for pigmentation of salmon, trout and shrimps; used for its antioxidant and other health benefits in nutraceutical industry; used in cosmetics for its skin care and anti-aging properties; and also used for fortification of foods and beverages. On commercial scale, astaxanthin is currently produced through chemical synthesis and also derived from natural sources such as Phaffia yeast, Paracoccus bacteria, shrimp bi-products and Haematococcus pluvialis (H. pluvialis) microalgae, with the current major natural source of astaxanthin being the Haematococcus pluvialis microalgae. In recent years, there has been a growing trend toward using natural ingredients in all forms of food nutrients including the nutraceutical and cosmetic markets, resulting from increasing concerns for consumer safety and regulatory issues over the introduction of synthetic chemicals into the human food chain. The demand for natural astaxanthin derived from Haematococcus pluvialis algae in the global market has been sky-rocketing in recent years owing to increasing consumer awareness of its health benefits. Astaxanthin products analyzed in this study include Synthetic Astaxanthin, Haematococcus pluvialis Microalgae Astaxanthin and astaxanthin rich Paracoccus bacteria. End-use application markets covered in the report are Aqua Feed, Nutraceuticals, Cosmetics and Food & Beverages. The report also provides a special focus on various astaxanthin production technologies employed by key market players, including Chemical Synthesis; Microalgae Cultivation, Harvesting, Drying and Astaxanthin Extraction; and Bacteria Fermentation. Key Topics Covered: 1. INTRODUCTION 2. COMMERCIAL ASTAXANTHIN PRODUCTION TECHNOLOGIES 3. KEY MARKET TRENDS 4. INDUSTRY LANDSCAPE 5. KEY BUSINESS TRENDS 6. GLOBAL MARKET OVERVIEW PART B: REGIONAL MARKET PERSPECTIVE REGIONAL MARKET OVERVIEW 1. NORTH AMERICA 2. EUROPE 3. JAPAN 4. ASIA-PACIFIC 5. SOUTH AMERICA 6. REST OF WORLD PART C: GUIDE TO THE INDUSTRY PART
ANNEXURE 1. RESEARCH METHODOLOGY 2. FEEDBACK Companies Mentioned: Partial List of the Companies Featured - Algatechnologies Ltd. - BASF SE - Beijing Gingko Group (BGG) Biological Technology Co Ltd - Biogenic Co Ltd - Cyanotech Corporation - DSM NV - Fenchem Biotek Ltd - Fuji Chemical Industry Co Ltd (Astareal Co Ltd) - Igene Biotechnology, Inc. - Jingzhou Natural Astaxanthin Inc. - JX Nippon Oil & Energy Corporation - Parry Nutraceuticals Ltd. - Pigmentos Naturales SA - Shandong Wefirst Biotechnology Co Ltd - Supreme Biotechnologies NZ Ltd - Valensa International (U. S. Nutraceuticals LLC) - Yunnan Alphy Biotech Co Ltd - Zhejiang NHU Co Ltd For more information visit http://www.researchandmarkets.com/research/558wqg/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CYAN: 3.90 (-0.10)
Astaxanthin Ingredients for the US Human Nutrition Market - 2015 Outlook and Trends
M2 - Wed Mar 18, 6:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d7ws3v/astaxanthin) has announced the addition of the "Astaxanthin Ingredients for the US Human Nutrition MarketOutlook and Trends " report to their offering. This is a market insight into the astaxanthin for human nutrition market. Astaxanthin is a natural antioxidant ingredient in human health (eye health, prevention of aging, and skin care) incorporated into dietary supplements, nutraceuticals, and vitamin and mineral supplements. The regional scope of this market insight is the United States, but global insights have been provided, highlighting the need for natural antioxidants in human health conditions. Market drivers and restraints, market estimates and growth, value chain and competitive structure, and technology and production have been discussed in detail. Profiles of top suppliers of astaxanthin are included, and their products are analyzed. Key Topics Covered: 1. Astaxanthin Ingredients for the US Human Nutrition Market - Outlook and Trends 2. Executive Summary - Key Findings - Opportunity Dashboard - Market Snapshot - Industry Challenges Summary - Drivers and Restraints Summary - Value Chain Analysis - Competitive Analysis - Astaxanthin Industry Best Practices 3. Market Overview - Introduction - Applications Overview - Revenue Forecast - Global Revenue by Region - Revenue by End Application 4.Market Drivers Restraints - Industry Challenges Summary - Industry Challenges Explained - Drivers and Restraints Summary - Drivers Explained - Restraints Explained 5. Value Chain and Competitive Structure - Value Chain Analysis - Competitive Analysis - Global Astaxanthin Suppliers - Other Brands Containing Astaxanthin 6.Technology Overview - Astaxanthin Commercial Sources - Astaxanthin Approval Status - Astaxanthin Uses by Source - Astaxanthin Molecular Forms - Astaxanthin Prices and Sustainability - Impact of Technology on Prices - Commercial Limitations of Natural Astaxanthic - Astaxanthin Shares by Source 7. Production Overview - Microalgal/AstaREAL - Microalgal/Cyanotech - Microalgal/Valensa - Yeast-based/Igene - Enzymatic Conversion/ Valensa 8. Astaxanthin Supplier Profiles - Fuji Chemical Industry Co., Ltd. - Cyanotech Corporation - Valensa International - Piveg, Inc - Igene Biotechnology, Inc. - Mera Pharmaceuticals, Inc. 9. Natural Antioxidant Ingredients Market - Overview - Definitions - Revenue and CAGR (2014-2019) by Region - Green, Safe, and Healthy Trends Drive Demand - Increasing Consumption of Natural/Organic Food Drives Demand - Need to Increase Food Safety (Shelf-life) and Reduce Wastage Drives Demand - Zero-Trans Fat and Need to Reduce Food Spoilage Drive Demand - Need for More Sustainable Sources - Opportunities in the Companion Animal Feeds Market For more information visit http://www.researchandmarkets.com/research/d7...staxanthin
CYAN: 3.90 (-0.10)
Nasdaq stocks posting largest percentage decreases
AP - Wed Feb 18, 12:18PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
SYKE: 27.94 (+0.26), ENPH: 1.48 (+0.04), FOSL: 27.34 (+0.53), PERY: 19.61 (+0.14), AXDX: 28.29 (+1.09), CERU: 0.95 (-0.02), CYAN: 3.90 (-0.10), SONS: 8.59 (+0.06), GRMN: 47.75 (+0.52), HOLI: 21.75 (+0.28), AGIO: 47.57 (+0.95), VBLT: 4.54 (-0.17), DWSN: 7.10 (+0.02), FBSS: 14.50 (+0.17)
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2015
BusinessWire - Thu Feb 12, 7:00AM CST
---- New Astaxanthin extraction system to begin operating in 1QFY2016, speeding production and reducing costs --
CYAN: 3.90 (-0.10)
Cyanotech elects David L. Vied as director
M2 - Fri Jan 30, 2:10AM CST
Microalgae technology company Cyanotech (Nasdaq:CYAN) reported on Wednesday the addition of David L. Vied as an independent director of its board of directors.
CYAN: 3.90 (-0.10)
Cyanotech Names David L. Vied as a Director
BusinessWire - Wed Jan 28, 8:02AM CST
David L. Vied of Los Angeles, CA has been elected as a Director by the Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN). Mr. Vied was determined under Nasdaq rules to be an independent Director of the Board, which is now comprised of four independent directors and two management directors.
CYAN: 3.90 (-0.10)
Nasdaq stocks posting largest volume decreases
AP - Tue Jan 27, 5:09PM CST
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
RGCO: 23.73 (-0.54), PSBH: 10.25 (-0.05), LSBK: 13.28 (+0.01), NAII: 10.16 (+0.24), CYAN: 3.90 (-0.10), VYFC: 21.36 (+0.31), GPIC: 10.12 (-0.58), AMIC: 24.72 (-0.05), UNTY: 12.19 (-0.06), UCBA: 15.63 (-0.12), CFNB: 14.51 (-0.01), PBSK: 18.90 (+0.15)
Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2017
BusinessWire - Mon Aug 15, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the first quarter of fiscal year 2017, ended June 30, 2016.
CYAN: 3.90 (-0.10)
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2016
BusinessWire - Thu Jun 23, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the fourth quarter ended March 31, 2016 and fiscal year 2016.
CYAN: 3.90 (-0.10)
Cyanotech Names David Mulder as a Director
BusinessWire - Mon May 23, 7:00AM CDT
The Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN) named David Mulder as a Director of the Company effective May 17, 2016. He replaces Ralph Carlton, who resigned.
CYAN: 3.90 (-0.10)
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2016
BusinessWire - Thu Nov 12, 7:00AM CST
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the second quarter and first six months of fiscal year 2016, ended September 30, 2015.
CYAN: 3.90 (-0.10)
Nutrex Hawaii Announces New Gluten-Free, Grass Free Green Complete(R) Superfood Powder
BusinessWire - Tue Aug 18, 8:00AM CDT
Today, Nutrex Hawaii announced the new blend for Green Complete(R) Superfood Powder. Green Complete Superfood Powder is designed to naturally boost energy and immunity*. The new blend allows greens fans to get their full three gram serving of Hawaiian Spirulina in a certified gluten-free and grass free combination.
CYAN: 3.90 (-0.10)
Cyanotech's net loss narrows to USD105,000 in Q1 fiscal 2016
M2 - Mon Aug 10, 3:06AM CDT
Health products company Cyanotech (Nasdaq CM:CYAN) stated on Friday its net loss was of USD105,000 (USD0.02 per diluted share) for the first quarter of fiscal year 2016, ended 30 June 2015.
CYAN: 3.90 (-0.10)
Cyanotech Adds Astaxanthin Productivity Enhancement
BusinessWire - Fri Jun 12, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), reported today that its new Astaxanthin extraction system has been installed at Cyanotech's production facility at Kailua-Kona, Hawaii and is in operation.
CYAN: 3.90 (-0.10)
Carotenoids Market by Type, Source, Application, & by Region - Global Trends & Forecasts to 2019
M2 - Wed Apr 22, 3:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jx5f7f/carotenoids) has announced the addition of the "Carotenoids Market by Type (Astaxanthin, Beta-Carotene, Canthaxanthin, Lutein, Lycopene, & Zeaxanthin), Source (Synthetic and Natural), Application (Supplements, Food, Feed, and Cosmetics), & by Region - Global Trends & Forecasts to 2019" report to their offering. The market was valued at $1,161.78 million in 2013. It is projected to grow at a CAGR of 3.5% from 2014 to reach $1,428.12 million by 2019 Carotenoids are one of the most important classes of plant pigments and play a very important role in defining the quality parameter of fruit and vegetables. Carotenoids are found mainly in plants, algae, and photosynthetic bacteria; however humans and animals have to rely upon food as a source of these compounds. Carotenoids are gaining significance due to high health benefits, increasing its end-use application and its easy availability. Aging population of the world, especially in the European and North American countries has also boosted the market globally. The market was dominated by Europe in 2013, which accounted for around 42% of the total carotenoids market. However, Asia-Pacific is projected to be the fastest-growing market for the period considered for this study, due to growing demand for food and animal feed and increasing health awareness amongst people. In terms of applications, animal feed is projected to be the largest market for carotenoids from 2014 to 2019; however the supplements market is projected to be the fastest-growing market for the period under study. On the other hand, natural carotenoids are projected to grow at a CAGR of 4.0% for the period under consideration owing to increasing consumers' preferences for natural products and health awareness and concerns. The carotenoids market is characterized by intense competition due to the presence of a large number of both large- and small-scale firms. Expansions, acquisitions, agreements, and new product launches are the key strategies adopted by market players to ensure their growth in the market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Carotenoids Market, By Type 8 Carotenoids Market, By Application 9 Carotenoids Market, By Source 10 Carotenoids Market, By Region 11 Competitive Landscape 12 Company Profiles - Allied Biotech Corporation - BASF SE - CHR. Hansen A/S - Carotech Berhad - Cyanotech Corporation - D.D. Williamson & Co., Inc. - DSM N.V. - Dohler Group - FMC Corporation - Kemin Industries, Inc. For more information visit http://www.researchandmarkets.com/research/jx...arotenoids
CYAN: 3.90 (-0.10), FMC: 47.78 (-0.01)
Global Astaxanthin Market 2015 - Sources, Technologies and Application
M2 - Fri Mar 20, 10:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/558wqg/global) has announced the addition of the "Global Astaxanthin Market - Sources, Technologies and Application" report to their offering. Global market for both synthetic and natural source astaxanthin in aqua feed, nutraceuticals, cosmetics and food & beverages is estimated at 280 metric tons valued at US$447 million in 2014, is further projected to reach 670 metric tons valued at US$1.1 billion by 2020. Synthetic astaxanthin, astaxanthin rich Phaffia yeast and Paracoccus bacteria are predominantly used in the aquaculture sector, while the astaxanthin derived from H. pluvialis microalgae is the main source for human applications such as dietary supplements, cosmetics and food & beverages. Astaxanthin has been widely used in aquaculture industry for pigmentation of salmon, trout and shrimps; used for its antioxidant and other health benefits in nutraceutical industry; used in cosmetics for its skin care and anti-aging properties; and also used for fortification of foods and beverages. On commercial scale, astaxanthin is currently produced through chemical synthesis and also derived from natural sources such as Phaffia yeast, Paracoccus bacteria, shrimp bi-products and Haematococcus pluvialis (H. pluvialis) microalgae, with the current major natural source of astaxanthin being the Haematococcus pluvialis microalgae. In recent years, there has been a growing trend toward using natural ingredients in all forms of food nutrients including the nutraceutical and cosmetic markets, resulting from increasing concerns for consumer safety and regulatory issues over the introduction of synthetic chemicals into the human food chain. The demand for natural astaxanthin derived from Haematococcus pluvialis algae in the global market has been sky-rocketing in recent years owing to increasing consumer awareness of its health benefits. Astaxanthin products analyzed in this study include Synthetic Astaxanthin, Haematococcus pluvialis Microalgae Astaxanthin and astaxanthin rich Paracoccus bacteria. End-use application markets covered in the report are Aqua Feed, Nutraceuticals, Cosmetics and Food & Beverages. The report also provides a special focus on various astaxanthin production technologies employed by key market players, including Chemical Synthesis; Microalgae Cultivation, Harvesting, Drying and Astaxanthin Extraction; and Bacteria Fermentation. Key Topics Covered: 1. INTRODUCTION 2. COMMERCIAL ASTAXANTHIN PRODUCTION TECHNOLOGIES 3. KEY MARKET TRENDS 4. INDUSTRY LANDSCAPE 5. KEY BUSINESS TRENDS 6. GLOBAL MARKET OVERVIEW PART B: REGIONAL MARKET PERSPECTIVE REGIONAL MARKET OVERVIEW 1. NORTH AMERICA 2. EUROPE 3. JAPAN 4. ASIA-PACIFIC 5. SOUTH AMERICA 6. REST OF WORLD PART C: GUIDE TO THE INDUSTRY PART
ANNEXURE 1. RESEARCH METHODOLOGY 2. FEEDBACK Companies Mentioned: Partial List of the Companies Featured - Algatechnologies Ltd. - BASF SE - Beijing Gingko Group (BGG) Biological Technology Co Ltd - Biogenic Co Ltd - Cyanotech Corporation - DSM NV - Fenchem Biotek Ltd - Fuji Chemical Industry Co Ltd (Astareal Co Ltd) - Igene Biotechnology, Inc. - Jingzhou Natural Astaxanthin Inc. - JX Nippon Oil & Energy Corporation - Parry Nutraceuticals Ltd. - Pigmentos Naturales SA - Shandong Wefirst Biotechnology Co Ltd - Supreme Biotechnologies NZ Ltd - Valensa International (U. S. Nutraceuticals LLC) - Yunnan Alphy Biotech Co Ltd - Zhejiang NHU Co Ltd For more information visit http://www.researchandmarkets.com/research/558wqg/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CYAN: 3.90 (-0.10)
Astaxanthin Ingredients for the US Human Nutrition Market - 2015 Outlook and Trends
M2 - Wed Mar 18, 6:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d7ws3v/astaxanthin) has announced the addition of the "Astaxanthin Ingredients for the US Human Nutrition MarketOutlook and Trends " report to their offering. This is a market insight into the astaxanthin for human nutrition market. Astaxanthin is a natural antioxidant ingredient in human health (eye health, prevention of aging, and skin care) incorporated into dietary supplements, nutraceuticals, and vitamin and mineral supplements. The regional scope of this market insight is the United States, but global insights have been provided, highlighting the need for natural antioxidants in human health conditions. Market drivers and restraints, market estimates and growth, value chain and competitive structure, and technology and production have been discussed in detail. Profiles of top suppliers of astaxanthin are included, and their products are analyzed. Key Topics Covered: 1. Astaxanthin Ingredients for the US Human Nutrition Market - Outlook and Trends 2. Executive Summary - Key Findings - Opportunity Dashboard - Market Snapshot - Industry Challenges Summary - Drivers and Restraints Summary - Value Chain Analysis - Competitive Analysis - Astaxanthin Industry Best Practices 3. Market Overview - Introduction - Applications Overview - Revenue Forecast - Global Revenue by Region - Revenue by End Application 4.Market Drivers Restraints - Industry Challenges Summary - Industry Challenges Explained - Drivers and Restraints Summary - Drivers Explained - Restraints Explained 5. Value Chain and Competitive Structure - Value Chain Analysis - Competitive Analysis - Global Astaxanthin Suppliers - Other Brands Containing Astaxanthin 6.Technology Overview - Astaxanthin Commercial Sources - Astaxanthin Approval Status - Astaxanthin Uses by Source - Astaxanthin Molecular Forms - Astaxanthin Prices and Sustainability - Impact of Technology on Prices - Commercial Limitations of Natural Astaxanthic - Astaxanthin Shares by Source 7. Production Overview - Microalgal/AstaREAL - Microalgal/Cyanotech - Microalgal/Valensa - Yeast-based/Igene - Enzymatic Conversion/ Valensa 8. Astaxanthin Supplier Profiles - Fuji Chemical Industry Co., Ltd. - Cyanotech Corporation - Valensa International - Piveg, Inc - Igene Biotechnology, Inc. - Mera Pharmaceuticals, Inc. 9. Natural Antioxidant Ingredients Market - Overview - Definitions - Revenue and CAGR (2014-2019) by Region - Green, Safe, and Healthy Trends Drive Demand - Increasing Consumption of Natural/Organic Food Drives Demand - Need to Increase Food Safety (Shelf-life) and Reduce Wastage Drives Demand - Zero-Trans Fat and Need to Reduce Food Spoilage Drive Demand - Need for More Sustainable Sources - Opportunities in the Companion Animal Feeds Market For more information visit http://www.researchandmarkets.com/research/d7...staxanthin
CYAN: 3.90 (-0.10)
Nasdaq stocks posting largest percentage decreases
AP - Wed Feb 18, 12:18PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
SYKE: 27.94 (+0.26), ENPH: 1.48 (+0.04), FOSL: 27.34 (+0.53), PERY: 19.61 (+0.14), AXDX: 28.29 (+1.09), CERU: 0.95 (-0.02), CYAN: 3.90 (-0.10), SONS: 8.59 (+0.06), GRMN: 47.75 (+0.52), HOLI: 21.75 (+0.28), AGIO: 47.57 (+0.95), VBLT: 4.54 (-0.17), DWSN: 7.10 (+0.02), FBSS: 14.50 (+0.17)
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2015
BusinessWire - Thu Feb 12, 7:00AM CST
---- New Astaxanthin extraction system to begin operating in 1QFY2016, speeding production and reducing costs --
CYAN: 3.90 (-0.10)
Cyanotech elects David L. Vied as director
M2 - Fri Jan 30, 2:10AM CST
Microalgae technology company Cyanotech (Nasdaq:CYAN) reported on Wednesday the addition of David L. Vied as an independent director of its board of directors.
CYAN: 3.90 (-0.10)
Cyanotech Names David L. Vied as a Director
BusinessWire - Wed Jan 28, 8:02AM CST
David L. Vied of Los Angeles, CA has been elected as a Director by the Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN). Mr. Vied was determined under Nasdaq rules to be an independent Director of the Board, which is now comprised of four independent directors and two management directors.
CYAN: 3.90 (-0.10)
Nasdaq stocks posting largest volume decreases
AP - Tue Jan 27, 5:09PM CST
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
RGCO: 23.73 (-0.54), PSBH: 10.25 (-0.05), LSBK: 13.28 (+0.01), NAII: 10.16 (+0.24), CYAN: 3.90 (-0.10), VYFC: 21.36 (+0.31), GPIC: 10.12 (-0.58), AMIC: 24.72 (-0.05), UNTY: 12.19 (-0.06), UCBA: 15.63 (-0.12), CFNB: 14.51 (-0.01), PBSK: 18.90 (+0.15)
(0)
(0)Scroll down for more posts ▼